EP2111229
Pharmaceutical compositions comprising Activin-ActRIIA antagonists for use in preventing or treating breast cancer metastasis or breast cancer related bone loss
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.2.2008EP published:
10.4.2013EP application number:
08725118.7
EPO information:
European Patent Register
Max expiry date:
31.1.2028
Title:
Pharmaceutical compositions comprising Activin-ActRIIA antagonists for use in preventing or treating breast cancer metastasis or breast cancer related bone loss
Timeline
Today
1.2.2008EP application
10.4.2013EP Publication
Owner
Name:
Acceleron Pharma, Inc.Address:
128 Sidney Street, 02139, Cambridge, MA, US
Inventor
Name:
KNOPF, JohnAddress:
Carlisle, MA, US
Name:
SEEHRA, JasbirAddress:
Lexington, MA, US
Name:
KUMAR, RavindraAddress:
Acton, MA, US
Priority
Number:
899070 PDate:
1.2.2007Country:
US
Number:
540 PDate:
25.10.2007Country:
US
Classification
Categories:
A61P 35/04, A61K 38/17